The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
The Oral Absorption of Micro- and Nanoparticulates: Neither Exceptional Nor Unusual
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tomalia, D. A., Naylor, A. M., & Goddard, W. A. (1990) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199001381 · Cited by 3,211
Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma
WOTHERSPOON, A. (1991) · The Lancet · doi:10.1016/0140-6736(91)92035-z · Cited by 1,866
Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
Desai, M. P., Labhasetwar, V., Amidon, G. L., & Levy, R. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016085108889 · Cited by 941
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
Jani, P., Halbert, G. W., Langridge, J., & Florence, A. T. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb07033.x · Cited by 920
Self-citationBerg, R. D., & Garlington, A. W. (1979) · Infection and Immunity · doi:10.1128/iai.23.2.403-411.1979 · Cited by 841
Eldridge, J. H., Hammond, C. J., Meulbroek, J. A., Staas, J. K., Gilley, R. M., & Tice, T. R. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90133-e · Cited by 689
Isberg, R. R., & Falkow, S. (1985) · Nature · doi:10.1038/317262a0 · Cited by 517
Sanderson, I. R., & Walker, W. A. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90436-g · Cited by 474
The Uptake and Translocation of Latex Nanospheres and Microspheres after Oral Administration to Rats
Jani, P., Halbert, G. W., Langridge, J., & Florence, A. T. (1989) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1989.tb06377.x · Cited by 394
Self-citationThe prevalence of gut translocation in humans
Sedman, P. C., Macfle, J., Sagar, P., Mitchell, C. J., May, J., Mancey-Jones, B., & Johnstone, D. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90110-4 · Cited by 362
Cited by
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
Gupta, A. K., & Gupta, M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.10.012 · Cited by 6,771
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
Boisselier, E., & Astruc, D. (2009) · Chemical Society Reviews · doi:10.1039/b806051g · Cited by 2,842
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Biodegradable nanoparticles for drug delivery and targeting
Hans, M. L., & Lowman, A. M. (2002) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(02)00117-1 · Cited by 1,324
Sonavane, G., Tomoda, K., & Makino, K. (2008) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2008.07.004 · Cited by 1,100
Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus
Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y.-Y., Cone, R., & Hanes, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608611104 · Cited by 1,050
Nanotechnology: Intelligent Design to Treat Complex Disease
Couvreur, P., & Vauthier, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0284-8 · Cited by 948
Bioavailability of nanoparticles in nutrient and nutraceutical delivery
Acosta, E. (2009) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2008.01.002 · Cited by 874
Solid lipid nanoparticles as a drug delivery system for peptides and proteins☆
ALMEIDA, A., & SOUTO, E. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.007 · Cited by 814
Hillyer, J. F., & Albrecht, R. M. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1143 · Cited by 706
Müller, R. H., Gohla, S., & Keck, C. M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.01.007 · Cited by 702
Hussain, N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00152-1 · Cited by 680
Agrawal, M., Saraf, S., Saraf, S., Antimisiaris, S. G., Chougule, M. B., Shoyele, S. A., & Alexander, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.011 · Cited by 630
Alginate/Chitosan Nanoparticles are Effective for Oral Insulin Delivery
Sarmento, B., Ribeiro, A., Veiga, F., Sampaio, P., Neufeld, R., & Ferreira, D. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9367-4 · Cited by 617
Galindo-Rodriguez, S., Allémann, E., Fessi, H., & Doelker, E. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036917.75634.be · Cited by 602
Jung, T. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00084-9 · Cited by 588
Mittal, G., Sahana, D. K., Bhardwaj, V., & Ravi Kumar, M. N. V. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.016 · Cited by 551
Gold nanoparticles: opportunities and challenges in nanomedicine
Arvizo, R., Bhattacharya, R., & Mukherjee, P. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425241003777010 · Cited by 538
Recent Advances in the Theory of Filler Networking in Elastomers
Heinrich, G., & Klüppel, M. (2007) · Advances in Polymer Science · doi:10.1007/3-540-45362-8_1 · Cited by 537
Relevance of nano- and microplastics for freshwater ecosystems: A critical review
Triebskorn, R., Braunbeck, T., Grummt, T., Hanslik, L., Huppertsberg, S., Jekel, M., Knepper, T. P., Krais, S., Müller, Y. K., Pittroff, M., et al. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2018.11.023 · Cited by 507
Ponchel, G. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00040-4 · Cited by 494
Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs
Gershanik, T. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00089-8 · Cited by 477
Loeschner, K., Hadrup, N., Qvortrup, K., Larsen, A., Gao, X., Vogel, U., Mortensen, A., Lam, H., & Larsen, E. H. (2011) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-8-18 · Cited by 476
What do we (need to) know about the kinetic properties of nanoparticles in the body?
Hagens, W. I., Oomen, A. G., de Jong, W. H., Cassee, F. R., & Sips, A. J. A. M. (2007) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2007.07.006 · Cited by 464
Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules
Chen, M.-C., Mi, F.-L., Liao, Z.-X., Hsiao, C.-W., Sonaje, K., Chung, M.-F., Hsu, L.-W., & Sung, H.-W. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.010 · Cited by 451
Microplastics in Livers of European Anchovies (Engraulis encrasicolus, L.)
Collard, F., Gilbert, B., Compère, P., Eppe, G., Das, K., Jauniaux, T., & Parmentier, E. (2017) · Environmental Pollution · doi:10.1016/j.envpol.2017.07.089 · Cited by 438
Lectin-mediated drug targeting: history and applications
Bies, C., Lehr, C.-M., & Woodley, J. F. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.030 · Cited by 414
Stealth PLA-PEG nanoparticles as protein carriers for nasal administration
Tobío, M., Gref, R., Sánchez, A., Langer, R., & Alonso, M. J. (1998) · Pharmaceutical Research · doi:10.1023/a:1011922819926 · Cited by 402
Feng, S.-S., & Huang, G. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00364-3 · Cited by 398
Chitosan-Alginate Nanoparticles as a Novel Drug Delivery System for Nifedipine
The Second Hospital of Lanzhou University, L., Li, P., Dai, Y.-N., Pharmacy College of Lanzhou University, L., Zhang, J.-P., Lanzhou Institute of Chemical Physics, C. A. O. S., Wei, Q., & The Second Hospital of Lanzhou University, L. (2008) · International Journal of Biomedical Science · doi:10.59566/ijbs.2008.4221 · Cited by 386
Behrens, I., Pena, A. I. V., Alonso, M. J., & Kissel, T. (2002) · Pharmaceutical Research · doi:10.1023/a:1019854327540 · Cited by 372
Tobı́o, M., Sánchez, A., Vila, A., Soriano, I., Evora, C., Vila-Jato, J. L., & Alonso, M. J. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00157-5 · Cited by 368
Chitosan-based drug nanocarriers: Where do we stand?
Garcia-Fuentes, M., & Alonso, M. J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.017 · Cited by 353
Emerging Trends in Oral Delivery of Peptide and Protein Drugs
Mahato, R. I., Narang, A. S., Thoma, L., & Miller, D. D. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i23.30 · Cited by 352
Transmucosal macromolecular drug delivery
Prego, C., García, M., Torres, D., & Alonso, M. J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.030 · Cited by 338
Peters, R., Kramer, E., Oomen, A. G., Herrera Rivera, Z. E., Oegema, G., Tromp, P. C., Fokkink, R., Rietveld, A., Marvin, H. J. P., Weigel, S., et al. (2012) · ACS Nano · doi:10.1021/nn204728k · Cited by 336
Mu, L., & Feng, S. S. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00025-1 · Cited by 328
Sundar, S., Kundu, J., & Kundu, S. C. (2010) · Science and Technology of Advanced Materials · doi:10.1088/1468-6996/11/1/014104 · Cited by 326
Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P. (2010) · Nanomedicine · doi:10.2217/nnm.09.110 · Cited by 324
Nanomedicines for overcoming biological barriers
José Alonso, M. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.01.007 · Cited by 312
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas
Florence, A. T., & Hussain, N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00184-3 · Cited by 308
Self-citationToxicity of Cellulose Nanocrystals: A Review
Roman, M. (2015) · Industrial Biotechnology · doi:10.1089/ind.2014.0024 · Cited by 305
Mohamed, F., & van der Walle, C. F. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21082 · Cited by 299
Rana, S., Gallo, A., Srivastava, R. S., & Misra, R. D. K. (2007) · Acta Biomaterialia · doi:10.1016/j.actbio.2006.10.006 · Cited by 294
Gutierro, I., Hernández, R. M., Igartua, M., Gascón, A. R., & Pedraz, J. L. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00435-8 · Cited by 292
Yang, Y.-Y., Chia, H.-H., & Chung, T.-S. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00291-1 · Cited by 292
Gaillet, S., & Rouanet, J.-M. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.12.019 · Cited by 288
Solid lipid nanoparticles: an oral bioavailability enhancer vehicle
Harde, H., Das, M., & Jain, S. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.604311 · Cited by 281
Toxicology of Nanomaterials Used in Nanomedicine
Zhao, J., & Castranova, V. (2011) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2011.615113 · Cited by 280
Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol
Pandita, D., Kumar, S., Poonia, N., & Lather, V. (2014) · Food Research International · doi:10.1016/j.foodres.2014.05.059 · Cited by 273
Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules
Garcı́a-Fuentes, M., Torres, D., & Alonso, M. J. (2003) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(02)00053-x · Cited by 273
Lipid-Based Nanoparticles for Drug Delivery Systems
Samimi, S., Maghsoudnia, N., Eftekhari, R. B., & Dorkoosh, F. (2019) · Characterization and Biology of Nanomaterials for Drug Delivery · doi:10.1016/b978-0-12-814031-4.00003-9 · Cited by 266
Nanosystem drug targeting: Facing up to complex realities
Ruenraroengsak, P., Cook, J. M., & Florence, A. T. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.032 · Cited by 265
Self-citationSahana, D. K., Mittal, G., Bhardwaj, V., & Kumar, M. N. V. R. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21158 · Cited by 260
Oral Bioavailability of Insulin Contained in Polysaccharide Nanoparticles
Sarmento, B., Ribeiro, A., Veiga, F., Ferreira, D., & Neufeld, R. (2007) · Biomacromolecules · doi:10.1021/bm0703923 · Cited by 260
Nanoparticles and microparticles as vaccine-delivery systems
Singh, M., Chakrapani, A., & O’Hagan, D. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.797 · Cited by 259
Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics
ALLEMANN, E. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00039-8 · Cited by 257
The lectin–cell interaction and its implications to intestinal lectin-mediated drug delivery
Gabor, F., Bogner, E., Weissenboeck, A., & Wirth, M. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.015 · Cited by 247
Nanoparticle uptake by the oral route: Fulfilling its potential?
Florence, A. T. (2005) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2005.05.019 · Cited by 248
Self-citationLectin-mediated mucosal delivery of drugs and microparticles
Clark, M. A., Hirst, B. H., & Jepson, M. A. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00070-3 · Cited by 236
Jain, A. K., Swarnakar, N. K., Godugu, C., Singh, R. P., & Jain, S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.037 · Cited by 232
Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes
Jubeh, T. T., Barenholz, Y., & Rubinstein, A. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000019298.29561.cd · Cited by 164
Shakweh, M., Besnard, M., Nicolas, V., & Fattal, E. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.04.006 · Cited by 161
M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery
Jepson, M. A., Clark, M. A., & Hirst, B. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.018 · Cited by 130
Gaumet, M., Gurny, R., & Delie, F. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.11.015 · Cited by 115
Makhlof, A., Fujimoto, S., Tozuka, Y., & Takeuchi, H. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.12.008 · Cited by 90
Jain, A. K., Swarnakar, N. K., Das, M., Godugu, C., Singh, R. P., Rao, P. R., & Jain, S. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200011f · Cited by 89
Documentation of Microplastics in Tissues of Wild Coastal Animals
Haave, M., Gomiero, A., Schönheit, J., Nilsen, H., & Olsen, A. B. (2021) · Frontiers in Environmental Science · doi:10.3389/fenvs.2021.575058 · Cited by 80
“Uptake by the specialized epithelial M-cells of the gut associated lymphoid tissues like the Peyer’s patches has previously been discussed as a means of entry of MP in mammals for subsequent dissemination by lymph, blood and macrophages (Cannon and Swanson, 1992; Florence, 1997).”
BackgroundMechanisms of uptake and transport of particulate formulations in the small intestine
Delon, L., Gibson, R. J., Prestidge, C. A., & Thierry, B. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.006 · Cited by 64
Microparticle vaccine approaches to stimulate mucosal immunisation
Brayden, D. J., & Baird, A. W. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01445-9 · Cited by 64
Apical membrane receptors on intestinal M cells: potential targets for vaccine delivery
Brayden, D. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.036 · Cited by 43
PEG-stearate coated solid lipid nanoparticles as levothyroxine carriers for oral administration
Kashanian, S., & Rostami, E. (2014) · Journal of Nanoparticle Research · doi:10.1007/s11051-014-2293-6 · Cited by 28
“Controlled release efficiency and intestinal wrapped drug destruction in stomach and intestine and probable absorption of drug through the intestinal mucosa are two different models for drug distribution and absorption (Damge et al. 1990; Lowe and Temple 1994; Desai et al. 1996; Jani et al. 1990; Florence 1997).”
Background
Metadata
- Authors
- Florence, A. T.
- Venue
- Pharmaceutical Research
- Published
- 1997-03
- Volume
- 14
- Issue
- 3
- Pages
- 259-266
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W25951409
- Cited by
- 499
- References
- 60
- FWCI
- 16.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.